Salivary miRNAs and cytokines associated with diagnosis and prognosis of oral squamous cell carcinoma
Authors:
Open Access
- 22 January 2025
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 13, 1531016
Abstract
Oral squamous cell carcinoma (OSCC) is the most common malignant tumour in the oral and maxillofacial region. Early diagnosis can significantly improve the 5-year survival rate of patients with OSCC. Therefore, it is extremely important to differentiate OSCC patients early, easily and quickly. Human saliva contains a variety of components that can be used as biomarkers for the diagnosis and prognosis of OSCC. Studies have shown that salivary microRNAs (miRNAs) and cytokines are closely associated with the progression of OSCC. The aim of this review is to summarize the research progress of salivary biomarkers (miRNAs and cytokines) in the past 3 years, and to explore the possibility of using miRNAs and cytokines to improve the diagnosis and prognosis of OSCC.Keywords
Funding Information
- Natural Science Foundation of Jilin Province (YDZJ202401228ZYTS)
This publication has 114 references indexed in Scilit:
- Dysbiosis of pro‐inflammatory and anti‐inflammatory salivary cytokines during psoriasis providing a therapeutic window and a valuable diagnostic aid in futureBiotechnology and Applied Biochemistry, 2024
- Downregulation of salivary miR‐3928 as a potential biomarker in patients with oral squamous cell carcinoma and oral lichen planusClinical and Experimental Dental Research, 2024
- Interventions for the treatment of oral cavity and oropharyngeal cancers: surgical treatmentCochrane Database of Systematic Reviews, 2023
- The Prognostic Value of Human Papilloma Virus Infection in Oral Cavity Squamous Cell Carcinoma: A Meta‐AnalysisThe Laryngoscope, 2021
- microRNA‐based diagnostic and therapeutic applications in cancer medicineWIREs RNA, 2021
- Interleukin-8 in the Tumor Immune Niche: Lessons from Comparative Oncology2020
- A targeted proteomic strategy for the measurement of oral cancer candidate biomarkers in human salivaProteomics, 2015
- Betel quid chewing and the risk of oral and oropharyngeal cancers: A meta‐analysis with implications for cancer controlInternational Journal of Cancer, 2014
- Salivary MicroRNAs and Oral Cancer Detection2012
- Clinical significance of MMP‐2 and MMP‐9 in patients with oral cancerHead & Neck, 2007